BLRX
BioLineRX
BLRX
BLRX
16 hedge funds and large institutions have $302K invested in BioLineRX in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.55% more ownership
Funds ownership: 0% → 1.55% (+1.6%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
16
Holding in Top 10
–
Calls
$596K
Puts
$58K
Top Buyers
| 1 | +$68.3K | |
| 2 | +$64K | |
| 3 | +$63.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$50.7K |
| 5 |
Citigroup
New York
|
+$18.3K |
Top Sellers
| 1 | -$5.71K | |
| 2 | -$5.17K | |
| 3 | -$3.2K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.11K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$234 |
